focus -WSS

focus

author：leisure time 2025-09-30 00:09:55 - browse：439

Hyundai Kia Recall — FILE - A line of 2022 Santa Fe SUV's sit outside a Hyundai dealership Sunday, Sept. 12, 2021, in Littleton, Colo. In documents posted Thursday, Aug. 3, 2023, Hyundai and Kia are telling the owners of nearly 92,000 vehicles in the U.S. to park them outside because an electronic controller in an oil pump can overheat and cause fires. (AP Photo/David Zalubowski, File)The Associated Press

DETROIT -- Hyundai and Kia are telling the owners of nearly 92,000 vehicles in the U.S. to park them outside because an electronic controller in an oil pump can overheat and cause fires.

The affiliated Korean automakers are recalling the vehicles and also are telling owners to park them away from structures until repairs are made.

The recalls cover certain 2023 and 2024 Hyundai Palisades, as well some 2023 Tucson, Sonata, Elantra and Kona vehicles. Affected Kias include the 2023 Soul and Sportage as well as some 2023 and 2024 Seltos vehicles.

The companies say in documents posted Thursday by U.S. safety regulators that a capacitor on a circuit board in the oil pump assembly for the transmission may have been damaged by the supplier during manufacturing. That can cause a short-circuit and increase the risk of a fire.

Kia says it has six reports of melting components but no fires or injuries. Hyundai says it has confirmed four “thermal incidents” and no injuries.

Dealers will inspect and replace the oil pump controller if necessary. Hyundai owners will be notified by letter on Sept. 25. Kia will notify owners starting Sept. 28.

Previous article： The high cost of giving birth even with insurance
Next article： The stability of $0 premiums in Medicare Advantage

hotspot

WSS

Medicare innovation center doesn’t save money, experts say

Congress extends some pandemic preparedness programs

Some top drug companies are starting to take action on climate

The United States is paying nearly triple for new Covid vaccines

Setback for rare diseases as Taysha Gene Therapies pulls back

WHO recommends second malaria vaccine

hotspot

focus

Wikipedia

The cancer drug shortage isn’t new — and neither are the solutions

WHO recommends second malaria vaccine

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Nobel honors Karikó and Weissman's enduring partnership

Novavax promises a turnaround & Lilly roils the obesity market

Search called off for baby washed away in Pennsylvania flash flood

The cancer drug shortage isn’t new — and neither are the solutions

The battle over 'scope creep' and who gets to be called 'doctor'

Medicare proposal to cover medical devices draws a mixed reaction

A new crop of companies is reshaping the health data economy

focus

With Roe v Wade overturned, abortion providers work to adapt

European officials brace for rough respiratory virus season

Setback for rare diseases as Taysha Gene Therapies pulls back

What to watch for from Zogenix and Amicus clinical trials

Lawsuit highlights wrinkle for disputes over surprise medical bills

Roche’s Alnylam deal shows drug firms interested in heart drugs

hotspot

Wikipedia

focus

knowledge